Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -13.15M
March 31, 2026 -16.30M
December 31, 2025 -17.69M
September 30, 2025 -21.10M
June 30, 2025 -21.22M
March 31, 2025 -22.18M
December 31, 2024 -23.12M
September 30, 2024 -23.85M
June 30, 2024 -22.08M
March 31, 2024 -19.16M
December 31, 2023 -15.83M
September 30, 2023 -13.07M
June 30, 2023 -12.66M
March 31, 2023 -12.97M
December 31, 2022 -11.19M
September 30, 2022 -13.99M
June 30, 2022 -16.24M
March 31, 2022 -14.03M
December 31, 2021 -14.20M
September 30, 2021 -12.31M
June 30, 2021 -13.38M
March 31, 2021 -17.18M
December 31, 2020 -16.72M
September 30, 2020 -15.58M
June 30, 2020 -12.51M
Date Value
March 31, 2020 -15.31M
December 31, 2019 -15.72M
September 30, 2019 -17.11M
June 30, 2019 -17.52M
March 31, 2019 -11.81M
December 31, 2018 -10.94M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017 -6.735M
June 30, 2017 -6.682M
March 31, 2017 -5.468M
December 31, 2016 -4.530M
September 30, 2016
June 30, 2016
March 31, 2016
February 29, 2016
November 30, 2015
August 31, 2015
May 31, 2015
February 28, 2015 -0.0431M
November 30, 2014 -0.0145M
August 31, 2014 -0.0621M
May 31, 2014 -0.0595M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Biomerica, Inc. -3.421M
Univec, Inc. -15.55M
Lantheus Holdings, Inc. 412.80M
IDEXX Laboratories, Inc. 1.368B
Neogen Corp. 83.20M